| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8228921 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 5 Pages |
Abstract
Low-dose-rate brachytherapy can be used to treat lip carcinomas at Stages T1 and T2 as the only treatment with excellent results for local control and relapse-free survival. The benefits of brachytherapy are also cosmetic and functional, with 91% of patients having no side effects.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mireille Guibert, Isabelle David, Sébastien Vergez, Michel Rives, Thomas Filleron, Jacques Bonnet, Martine Delannes,